Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00022854 · ClinicalTrials.gov registry record · Phase 4
Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 270
- Enrollment target
NCT00022854: Completed Phase 4 study, sponsored by University of Pittsburgh.
NCT00022854 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 270 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00022854, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 270 participants
- Enrollment target
Study Summary
Anterior cruciate ligament (ACL) reconstruction is surgery that is done to repair a damaged ligament in the knee. In this study we will look at whether the femoral nerve block, a commonly used method for pain relief after ACL reconstruction, affects the way patients feel after surgery. We will study recovery during the first week after surgery and also 3-12 weeks after surgery. We will give all patients spinal anesthesia. Some patients will also receive a continuous femoral nerve block for 2 days, or by a single injection. We predict that patients who received the nerve block will have significantly improved pain results, compared to patients who did not receive the nerve block.
Interventions
- PROCEDURE Single-injection femoral nerve block
- PROCEDURE Femoral nerve block 60-hour continuous injection
- PROCEDURE Saline (control) injection into femoral nerve envelope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2001-05 |
| Est. Completion | 2005-01 |
| Phase | Phase 4 |
What the finished NCT00022854 record still lists
NCT00022854 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (48% lower).
The record links to 0 conditions, and to 3 interventions - of which Single-injection femoral nerve block is the first listed.
NCT00022854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00022854 about?
NCT00022854 is a clinical study titled "Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction". Anterior cruciate ligament (ACL) reconstruction is surgery that is done to repair a damaged ligament in the knee. In this study we will look at whether the femoral nerve block, a commonly used method for pain relief after ACL reconstruction, affects the way patients feel after surgery. We will study...
What is the current status of trial NCT00022854?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 270 participants. The study started on 2001-05. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00022854?
The interventions under investigation include: Single-injection femoral nerve block (PROCEDURE), Femoral nerve block 60-hour continuous injection (PROCEDURE), Saline (control) injection into femoral nerve envelope (PROCEDURE).
Who is sponsoring clinical trial NCT00022854?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00022854's enrollment target sits among peer trials
270 318th of 2000 higher than 1,682 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia